The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Osteoblast-Osteoclast Communication and Bone Homeostasis
Open accessAbstract
Bone remodeling is tightly regulated by a cross-talk between bone-forming osteoblasts and bone-resorbing osteoclasts. Osteoblasts and osteoclasts communicate with each other to regulate cellular behavior, survival and differentiation through direct cell-to-cell contact or through secretory proteins. A direct interaction between osteoblasts and osteoclasts allows bidirectional transduction of activation signals through EFNB2-EPHB4, FASL-FAS or SEMA3A-NRP1, regulating differentiation and survival of osteoblasts or osteoclasts. Alternatively, osteoblasts produce a range of different secretory molecules, including M-CSF, RANKL/OPG, WNT5A, and WNT16, that promote or suppress osteoclast differentiation and development. Osteoclasts also influence osteoblast formation and differentiation through secretion of soluble factors, including S1P, SEMA4D, CTHRC1 and C3. Here we review the current knowledge regarding membrane bound- and soluble factors governing cross-talk between osteoblasts and osteoclasts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670 · cited 2×
“OPG is considered to function as a decoy receptor binding to RANKL, negatively regulating osteoclast differentiation and activation by blocking the RANKL-RANK interaction [6,57].”
BackgroundOsteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809493 · Cited by 3,489
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351 · cited 2×
“Mice deficient in Tnfrsf11a (RANK) or Tnfsf11 (RANKL) are phenocopies of one another, indicating the essential role of this RANKL/RANK signaling axis in bone remodeling [48,51].”
BackgroundOsteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Normal Bone Anatomy and Physiology
Clarke, B. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04151206 · Cited by 2,192
Control of osteoblast function and regulation of bone mass
Harada, S.-I., & Rodan, G. A. (2003) · Nature · doi:10.1038/nature01660 · Cited by 1,444
The molecular understanding of osteoclast differentiation
Asagiri, M., & Takayanagi, H. (2007) · Bone · doi:10.1016/j.bone.2006.09.023 · Cited by 1,363
Matrix-embedded cells control osteoclast formation
Xiong, J., Onal, M., Jilka, R. L., Weinstein, R. S., Manolagas, S. C., & O'Brien, C. A. (2011) · Nature Medicine · doi:10.1038/nm.2448 · Cited by 1,304
Feng, X., & McDonald, J. M. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130203 · Cited by 1,272 · cited 3×
“bone resorption is tightly regulated without a major alteration in a net bone mass or mechanical strength under homeostatic conditions [2].”
BackgroundDenosumab in postmenopausal women with low bone mineral density.
McClung, M. R., Lewiecki, E. M., Cohen, S. B., Bolognese, M. A., Woodson, G. C., Moffett, A. H., Peacock, M., Miller, P. D., Lederman, S. N., Chesnut, C. H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044459 · Cited by 1,228
Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201
Estrada, K., Styrkarsdottir, U., Evangelou, E., Hsu, Y.-H., Duncan, E. L., Ntzani, E. E., Oei, L., Albagha, O. M. E., Amin, N., Kemp, J. P., et al. (2012) · Nature Genetics · doi:10.1038/ng.2249 · Cited by 1,174
Sambrook, P., & Cooper, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68891-0 · Cited by 1,165
TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
Tang, Y., Wu, X., Lei, W., Pang, L., Wan, C., Shi, Z., Zhao, L., Nagy, T. R., Peng, X., Hu, J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1979 · Cited by 1,165
Mechanisms and functions of eph and ephrin signalling
Kullander, K., & Klein, R. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm856 · Cited by 1,156
Building strong bones: molecular regulation of the osteoblast lineage
Long, F. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3254 · Cited by 1,141
Li, J., Sarosi, I., Yan, X.-Q., Morony, S., Capparelli, C., Tan, H.-L., McCabe, S., Elliott, R., Scully, S., Van, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1566 · Cited by 1,119
The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules
Kolodkin, A. L., Matthes, D. J., & Goodman, C. S. (1993) · Cell · doi:10.1016/0092-8674(93)90625-z · Cited by 963
The Fas Signaling Pathway: More Than a Paradigm
Wajant, H. (2002) · Science · doi:10.1126/science.1071553 · Cited by 957
Khosla, S., Oursler, M. J., & Monroe, D. G. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.03.008 · Cited by 943
Regulation of osteoblastogenesis and bone mass by Wnt10b
Bennett, C. N., Longo, K. A., Wright, W. S., Suva, L. J., Lane, T. F., Hankenson, K. D., & MacDougald, O. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408742102 · Cited by 881
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
Zhao, C., Irie, N., Takada, Y., Shimoda, K., Miyamoto, T., Nishiwaki, T., Suda, T., & Matsuo, K. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.012 · Cited by 777
Bekker, P. J., Holloway, D. L., Rasmussen, A. S., Murphy, R., Martin, S. W., Leese, P. T., Holmes, G. B., Dunstan, C. R., & DePaoli, A. M. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040305 · Cited by 771
Discovery of a periosteal stem cell mediating intramembranous bone formation
Debnath, S., Yallowitz, A. R., McCormick, J., Lalani, S., Zhang, T., Xu, R., Li, N., Liu, Y., Yang, Y. S., Eiseman, M., et al. (2018) · Nature · doi:10.1038/s41586-018-0554-8 · Cited by 683
Self-citationGenetic Control of Bone Formation
Karsenty, G., Kronenberg, H. M., & Settembre, C. (2009) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113308 · Cited by 667
Theoleyre, S., Wittrant, Y., Tat, S. K., Fortun, Y., Redini, F., & Heymann, D. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.06.004 · Cited by 663
Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells
Xian, L., Wu, X., Pang, L., Lou, M., Rosen, C. J., Qiu, T., Crane, J., Frassica, F., Zhang, L., Rodriguez, J. P., et al. (2012) · Nature Medicine · doi:10.1038/nm.2793 · Cited by 631
SOST is a target gene for PTH in bone
Keller, H., & Kneissel, M. (2005) · Bone · doi:10.1016/j.bone.2005.03.018 · Cited by 616
The extracellular matrix and transforming growth factor-β1: Tale of a strained relationship
Hinz, B. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.05.006 · Cited by 608
Osteoprotection by semaphorin 3A
Hayashi, M., Nakashima, T., Taniguchi, M., Kodama, T., Kumanogoh, A., & Takayanagi, H. (2012) · Nature · doi:10.1038/nature11000 · Cited by 606
Semaphorin III is needed for normal patterning and growth of nerves, bones and heart
Behar, O., Golden, J. A., Mashimo, H., Schoen, F. J., & Fishman, M. C. (1996) · Nature · doi:10.1038/383525a0 · Cited by 583
Osteopetrosis: genetics, treatment and new insights into osteoclast function
Sobacchi, C., Schulz, A., Coxon, F. P., Villa, A., & Helfrich, M. H. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.137 · Cited by 580
Coupling of bone resorption and formation by RANKL reverse signalling
Ikebuchi, Y., Aoki, S., Honma, M., Hayashi, M., Sugamori, Y., Khan, M., Kariya, Y., Kato, G., Tabata, Y., Penninger, J. M., et al. (2018) · Nature · doi:10.1038/s41586-018-0482-7 · Cited by 557
Parathyroid hormone: anabolic and catabolic actions on the skeleton
Silva, B. C., & Bilezikian, J. P. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.03.005 · Cited by 557
Pederson, L., Ruan, M., Westendorf, J. J., Khosla, S., & Oursler, M. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805133106 · Cited by 556
Maeda, K., Kobayashi, Y., Udagawa, N., Uehara, S., Ishihara, A., Mizoguchi, T., Kikuchi, Y., Takada, I., Kato, S., Kani, S., et al. (2012) · Nature Medicine · doi:10.1038/nm.2653 · Cited by 542
Xu, F., & Teitelbaum, S. L. (2013) · Bone Research · doi:10.4248/br201301003 · Cited by 523
Li, Y., Toraldo, G., Li, A., Yang, X., Zhang, H., Qian, W.-P., & Weitzmann, M. N. (2007) · Blood · doi:10.1182/blood-2006-07-037994 · Cited by 520
Estrogen Inhibits Bone Resorption by Directly Inducing Apoptosis of the Bone-resorbing Osteoclasts
Kameda, T., Mano, H., Yuasa, T., Mori, Y., Miyazawa, K., Shiokawa, M., Nakamaru, Y., Hiroi, E., Hiura, K., Kameda, A., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.4.489 · Cited by 519
Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis
Ishii, M., Egen, J. G., Klauschen, F., Meier-Schellersheim, M., Saeki, Y., Vacher, J., Proia, R. L., & Germain, R. N. (2009) · Nature · doi:10.1038/nature07713 · Cited by 515
Crockett, J. C., Rogers, M. J., Coxon, F. P., Hocking, L. J., & Helfrich, M. H. (2011) · Journal of Cell Science · doi:10.1242/jcs.063032 · Cited by 500
Suppression of bone formation by osteoclastic expression of semaphorin 4D
Negishi-Koga, T., Shinohara, M., Komatsu, N., Bito, H., Kodama, T., Friedel, R. H., & Takayanagi, H. (2011) · Nature Medicine · doi:10.1038/nm.2489 · Cited by 498
Osteoblast Differentiation and Bone Matrix Formation In Vivo and In Vitro
Blair, H. C., Larrouture, Q. C., Li, Y., Lin, H., Beer-Stoltz, D., Liu, L., Tuan, R. S., Robinson, L. J., Schlesinger, P. H., & Nelson, D. J. (2017) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2016.0454 · Cited by 484
Clinical targeting of the TNF and TNFR superfamilies
Croft, M., Benedict, C. A., & Ware, C. F. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3930 · Cited by 456
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis
Langdahl, B., Ferrari, S., & Dempster, D. W. (2016) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x16670154 · Cited by 432
Sema3A regulates bone-mass accrual through sensory innervations
Fukuda, T., Takeda, S., Xu, R., Ochi, H., Sunamura, S., Sato, T., Shibata, S., Yoshida, Y., Gu, Z., Kimura, A., et al. (2013) · Nature · doi:10.1038/nature12115 · Cited by 415
The Bone Lining Cell: Its Role in Cleaning Howship's Lacunae and Initiating Bone Formation
Everts, V., Delaissé, J. M., Korper, W., Jansen, D. C., Tigchelaar-Gutter, W., Saftig, P., & Beertsen, W. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.1.77 · Cited by 411 · cited 1×
“During bone remodeling, osteoblasts and osteoclasts communicate through cell-to-cell direct contact [25].”
BackgroundParfitt, A. M. (1982) · Metabolic Bone Disease and Related Research · doi:10.1016/0221-8747(82)90002-9 · Cited by 399
Osteoclasts: more than ‘bone eaters’
Charles, J. F., & Aliprantis, A. O. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.06.001 · Cited by 391
Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
O'Brien, C. A., Plotkin, L. I., Galli, C., Goellner, J. J., Gortazar, A. R., Allen, M. R., Robling, A. G., Bouxsein, M., Schipani, E., Turner, C. H., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002942 · Cited by 390
Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate
Fan, Y., Hanai, J.-I., Le, P. T., Bi, R., Maridas, D., DeMambro, V., Figueroa, C. A., Kir, S., Zhou, X., Mannstadt, M., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.01.001 · Cited by 390
Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures
Movérare-Skrtic, S., Henning, P., Liu, X., Nagano, K., Saito, H., Börjesson, A. E., Sjögren, K., Windahl, S. H., Farman, H., Kindlund, B., et al. (2014) · Nature Medicine · doi:10.1038/nm.3654 · Cited by 361
Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival
Krum, S. A., Miranda‐Carboni, G. A., Hauschka, P. V., Carroll, J. S., Lane, T. F., Freedman, L. P., & Brown, M. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601984 · Cited by 353
Ishizuya, T., Yokose, S., Hori, M., Noda, T., Suda, T., Yoshiki, S., & Yamaguchi, A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119491 · Cited by 349
Suggested Sequential Mode of Control of Changes in Cell Behaviour in Adult Bone Remodelling
HATTNER, R., EPKER, B. N., & FROST, H. M. (1965) · Nature · doi:10.1038/206489a0 · Cited by 342
MANAGEMENT OF ENDOCRINE DISEASE: Secondary osteoporosis: pathophysiology and management
Mirza, F., & Canalis, E. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0118 · Cited by 331
Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation
Lotinun, S., Kiviranta, R., Matsubara, T., Alzate, J. A., Neff, L., Lüth, A., Koskivirta, I., Kleuser, B., Vacher, J., Vuorio, E., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64840 · Cited by 328
Ryu, J., Kim, H. J., Chang, E., Huang, H., Banno, Y., & Kim, H. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601430 · Cited by 317
Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis
Costa, A. G., Cusano, N. E., Silva, B. C., Cremers, S., & Bilezikian, J. P. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.77 · Cited by 287
Osteoclasts Provide Coupling Signals to Osteoblast Lineage Cells Through Multiple Mechanisms
Sims, N. A., & Martin, T. J. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034425 · Cited by 286
The role of Fas ligand in immune privilege
Green, D. R., & Ferguson, T. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35103104 · Cited by 284
Wnt10b Increases Postnatal Bone Formation by Enhancing Osteoblast Differentiation
Bennett, C. N., Ouyang, H., Ma, Y. L., Zeng, Q., Gerin, I., Sousa, K. M., Lane, T. F., Krishnan, V., Hankenson, K. D., & MacDougald, O. A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070810 · Cited by 281
Howard, G. A., Bottemiller, B. L., Turner, R. T., Rader, J. I., & Baylink, D. J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.5.3204 · Cited by 266
Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned
Drake, M. T., Clarke, B. L., Oursler, M. J., & Khosla, S. (2017) · Endocrine Reviews · doi:10.1210/er.2015-1114 · Cited by 266
Stanley, E. R., Cifone, M., Heard, P. M., & Defendi, V (1976) · The Journal of experimental medicine · doi:10.1084/jem.143.3.631 · Cited by 262
Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation
Takeshita, S., Fumoto, T., Matsuoka, K., Park, K.-A., Aburatani, H., Kato, S., Ito, M., & Ikeda, K. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69493 · Cited by 249
Frost, H. M. (1964) · Medical Entomology and Zoology · Cited by 232
Osteoclast-Derived Complement Component 3a Stimulates Osteoblast Differentiation
Matsuoka, K., Park, K.-A., Ito, M., Ikeda, K., & Takeshita, S. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2187 · Cited by 216
Osteocytic signalling pathways as therapeutic targets for bone fragility
Plotkin, L. I., & Bellido, T. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.71 · Cited by 206
Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II
Mohan, S., Jennings, J. C., Linkhart, T. A., & Baylink, D. J. (1988) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(88)90127-4 · Cited by 203
Zhu, L., Tang, Y., Li, X.-Y., Keller, E. T., Yang, J., Cho, J.-S., Feinberg, T. Y., & Weiss, S. J. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw6143 · Cited by 178
Dallas, S. L., Park-Snyder, S., Miyazono, K., Twardzik, D., Mundy, G. R., & Bonewald, L. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37449-5 · Cited by 171
Medina-Gomez, C., Kemp, J. P., Estrada, K., Eriksson, J., Liu, J., Reppe, S., Evans, D. M., Heppe, D. H. M., Vandenput, L., Herrera, L., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002718 · Cited by 165
Merck & Co. drops osteoporosis drug odanacatib
Mullard, A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.207 · Cited by 159
Mizuno, A., Kanno, T., HOSHI, M., Shibata, O., Yano, K., Fujise, N., Kinosaki, M., Yamaguchi, K., Tsuda, E., Murakami, A., et al. (2002) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740200049 · Cited by 156
The osteoclast: review of ultrastructure, origin, and structure-function relationship.
Göthlin, G., & Ericsson, J. L. E. (1976) · PubMed · Cited by 155
Xiong, J., Cawley, K., Piemontese, M., Fujiwara, Y., Zhao, H., Goellner, J. J., & O’Brien, C. A. (2018) · Nature Communications · doi:10.1038/s41467-018-05244-y · Cited by 144
Decreased Bone Turnover and Deterioration of Bone Structure in Two Cases of Pycnodysostosis
Fratzl‐Zelman, N., Valenta, A., Roschger, P., Nader, A., Gelb, B. D., Fratzl, P., & Klaushofer, K. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031055 · Cited by 144
Understanding Coupling between Bone Resorption and Formation
Andersen, T. L., Abdelgawad, M. E., Kristensen, H. B., Hauge, E. M., Rolighed, L., Bollerslev, J., Kjærsgaard-Andersen, P., & Delaisse, J.-M. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.03.006 · Cited by 137
Wang, L., Liu, S., Zhao, Y., Liu, D., Liu, Y., Chen, C., Karray, S., Shi, S., & Jin, Y. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.14 · Cited by 133
Targeting osteoclast-osteoblast communication
Cao, X. (2011) · Nature Medicine · doi:10.1038/nm.2499 · Cited by 129
Insulin-like growth factors I and II are present in the skeletal tissues of ten vertebrates
Bautista, C. M., Mohan, S., & Baylink, D. J. (1990) · Metabolism · doi:10.1016/0026-0495(90)90154-5 · Cited by 124
Takyar, F. M., Tonna, S. J., Ho, P. W. M., Crimeen‐Irwin, B., Baker, E. K., Martin, T. J., & Sims, N. A. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1820 · Cited by 108
Koller, D. L., Zheng, H., Karasik, D., Yerges‐Armstrong, L. M., Liu, C., McGuigan, F. E., Kemp, J. P., Giroux, S., Lai, D., Edenberg, H. J., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1796 · Cited by 104
EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis
Tonna, S. J., Takyar, F. M., Vrahnas, C., Crimeen‐Irwin, B., Ho, P. W. M., Poulton, I. J., Brennan, H. J., McGregor, N. E., Allan, E. H., Nguyen, H., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-254300 · Cited by 100
M-CSF: HAEMATOPOIETIC GROWTH FACTOR OR INFLAMMATORY CYTOKINE?
Fixe, P., & Praloran, V. (1998) · Cytokine · doi:10.1006/cyto.1997.0249 · Cited by 90
Semaphorin 3A: A new player in bone remodeling
Xu, R. (2013) · Cell Adhesion & Migration · doi:10.4161/cam.27752 · Cited by 70
Sims, N. A., & Ng, K. W. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0196-1 · Cited by 70
Chondrocytic EphrinB2 promotes cartilage destruction by osteoclasts in endochondral ossification
Tonna, S. J., Poulton, I. J., Taykar, F., Ho, P. W. M., Tonkin, B. A., Crimeen‐Irwin, B., Tatarczuch, L., McGregor, N. E., Mackie, E. J., Martin, T. J., et al. (2016) · Development · doi:10.1242/dev.125625 · Cited by 32
Recker, R. R., Dempster, D. W., Langdahl, B. L., Giezek, H., Clark, S., Ellis, G., Villiers, T. D., Valter, I., Zerbini, C. A. F., Cohn, D., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3994 · Cited by 31
Lacey, D. L., Erdmann, J. M., Shima, M., Kling, S. J., Matayoshi, A., Ohara, J., & Perkins, S. L. (1994) · Calcified Tissue International · doi:10.1007/bf00310164 · Cited by 21
Medina‐Gómez, C., Kemp, J. P., Estrada, K., et al. (2012) · Bone · doi:10.1016/j.bone.2012.02.085 · Cited by 8
Cited by
Huang, J., Wu, Y., Sun, J., Li, X., Geng, X., Zhao, M., Sun, T., & Fan, Z. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.125629 · Cited by 540
Advances in pathogenesis and therapeutic strategies for osteoporosis
Song, S., Guo, Y., Yang, Y., & Fu, D. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108168 · Cited by 476
Current Status of the Diagnosis and Management of Osteoporosis
Aibar-Almazán, A., Voltes-Martínez, A., Castellote-Caballero, Y., Afanador-Restrepo, D. F., Carcelén-Fraile, M. D. C., & López-Ruiz, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169465 · Cited by 412
Bone Tissue Engineering Scaffolds: Function of Multi‐Material Hierarchically Structured Scaffolds
Koushik, T. M., Miller, C. M., & Antunes, E. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202766 · Cited by 359
Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics
Chandra, A., & Rajawat, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073553 · Cited by 264
Metadata
- Authors
- Kim, J.-M., Lin, C., Stavre, Z., Greenblatt, M. B., & Shim, J.-H.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-09-10
- Volume
- 9
- Issue
- 9
- Pages
- 2073
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3083952170
- Cited by
- 1,178
- References
- 97
- FWCI
- 33.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.